Drug-induced disease
Many reports in the literature discuss aspects of drug-induced disease or injury which do not necessarily identify particular drugs or classes of drugs and their associated adverse drug reactions.
Such references might focus on the diagnosis, clinical pathology, pharmacology, pharmacogenomics or treatment of a drug-induced diseases or injury. Or analyse drug-induced diseases in relation to particular groups of the population (the young, the elderly, gender).
This area of the literature is accommodated in the Litt database under the category ‘Drug-induced disease (General)’ with further classification under the categories: skin; cardiovascular; central nervous system; endocrine/metabolic; gastrointestinal/hepatic etc. Litt’s weekly ‘Drug updates’ for subscribers lists ‘Drug-induced disease (General)’ as a separate heading with PubMed hyperlinks to references under these categories.
Drug-induced disease (Cardiovascular)
- (2024): Lee S+, Eur J Haematol Jun, Online ahead of print (pharmacovigilance / pharmacoepidemiology)
- (2024): Li B+, Arrhythm Electrophysiol Rev 13, e06 [REVIEW]
- (2024): Simon ST+, PLoS One 19(6), e0303261 [REVIEW] (pharmacogenomics)
- (2024): Tan H+, Front Cardiovasc Med May (e-Collection) (pharmacovigilance / pharmacoepidemiology)
- (2024): Tetterton-Kellner J+, Adv Drug Deliv Rev Jun, Online ahead of print [REVIEW]
- (2024): Woosley RL+, Heart Rhythm 21(6), 969-970 [REVIEW]
- (2024): Zhong Y+, Expert Opin Drug Saf Oct, Online ahead of print [REVIEW] (association) (pharmacovigilance / pharmacoepidemiology)
Drug-induced disease (Central Nervous System)
- (2024): Althubyani AA+, Drugs Context Jul (e-Collection) [REVIEW]
- (2024): Bakewell B+, Front Pharmacol May (e-Collection) (27 cases) [REVIEW]
- (2024): Barbosa-Azevedo M+, Toxicol Appl Pharmacol Sep, Online ahead of print [REVIEW]
- (2024): Dumont S+, J Sleep Res Sep, Online ahead of print [REVIEW]
- (2024): Garg K+, Brain Res Bull Feb (e-Collection) [REVIEW]
- (2024): Ismail O+, Eur J Clin Pharmacol Jul, Online ahead of print [REVIEW]
- (2024): Jia B+, Expert Opin Drug Saf May, Online ahead of print (pharmacovigilance / pharmacoepidemiology)
- (2024): Karatayev O+, Int J Mol Sci 25(15), 8341 [REVIEW]
- (2024): Kikegawa M+, Pharmaceuticals (Basel) 17(8), 1099 [REVIEW]
- (2024): Preti K+, Clin J Oncol Nurs 28(4), 351-357 [REVIEW]
- (2024): Shah VV+, JCO Precis Oncol 8, e2300312
- (2024): Shaia JK+, J Neuroophthalmol Aug, Online ahead of print8%
- (2024): Shatunova S+, Eur J Pharmacol Jul, Online ahead of print [REVIEW]
- (2024): Sunwoo Y+, Medicina (Kaunas) 60(7), 1028 [REVIEW] (pharmacovigilance / pharmacoepidemiology)
- (2024): Velasco R+, Eur J Neurol Jul, Online ahead of print
- (2024): Zhao C+, J Neurol Jun, Online ahead of print [REVIEW]
- (2023): Fusaroli M+, Psychiatry Clin Neurosci 77(3), 160-167 [REVIEW] (pharmacovigilance / pharmacoepidemiology)
- (2020): Tan MG+, Am J Clin Dermatol 21(2), 163-172 [REVIEW]
Drug-induced disease (Gastrointestinal/Hepatic)
- (2024): Alcorta A+, Pharmacol Ther Jul, Online ahead of print [REVIEW]
- (2024): Bessone F+, Clin Gastroenterol Hepatol Jul, Online ahead of print [REVIEW]
- (2024): Björnsson ES, Pharmaceuticals (Basel) 17(4), 520 [REVIEW]
- (2024): Chen M+, Front Artif Intell Jun (e-Collection)
- (2024): Cho FN+, BMC Infect Dis 24(1), 759 (pharmacogenomics)
- (2024): Domingo-Carnice A+, Med Clin (Barc) Oct, Online ahead of print
- (2024): Huang Y+, Molecules 29(11), 2663 [REVIEW]
- (2024): Li G+, Cell Mol Gastroenterol Hepatol May, Online ahead of print [REVIEW]
- (2024): Li W+, Front Pharmacol Sep (e-Collection) (pharmacovigilance / pharmacoepidemiology)
- (2024): López-Pascual E+, Int J Mol Sci 25(10), 5203 [REVIEW]
- (2024): Ma X+, Clin Ther May, Online ahead of print (Roussel Uclaf Causality Assessment Method)
- (2024): Müller SL+, Am J Case Rep 25, e944508 (1 case / male)
- (2024): Ravikumar B+, Arch Dis Child Educ Pract Ed May, Online ahead of print [REVIEW]
- (2024): Renaux Torres MC+, Support Care Cancer 32(7), 455 [REVIEW]
- (2024): Saowapa S+, Proc (Bayl Univ Med Cent) 37(5), 841-850 [REVIEW]
- (2024): Yu S+, Hepatol Int Jun, Online ahead of print
- (2023): Andrade RJ+, J Hepatol 79(3), 853-866 [REVIEW]
- (2023): Zhu R+, J Med Microbiol Nov (e-Collection) [REVIEW]
- (2022): Tan CK+, World J Gastroenterol 28(24), 2654-2666 [REVIEW]
- (1997): Desmet VJ, J Hepatol 26 Suppl 1, 31-5 [REVIEW]
Drug-induced disease (Ocular)
- (2024): Ang T+, Surv Ophthalmol 69(4), 622-631 [REVIEW]
- (2024): Cannilla H+, Tremor Other Hyperkinet Mov (N Y) May (e-Collection) [REVIEW]
- (2024): Cannilla H+, Tremor Other Hyperkinet Mov (N Y) May (e-Collection) [REVIEW]
- (2024): Lavasidis G+, Crit Rev Oncol Hematol Jun, Online ahead of print [REVIEW]
- (2024): Li L+, Front Endocrinol (Lausanne) May (e-Collection) [REVIEW] (Graves’ ophthalmopathy)
- (2024): Pepose JS+, Ophthalmology Sep, Online ahead of print
- (2023): Hu Y+, Front Endocrinol (Lausanne) May (e-Collection) [REVIEW] (Graves’ ophthalmopathy)
Drug-induced disease (Renal)
- (2024): Connor S+, Toxicol Res (Camb) Aug (e-Collection) [REVIEW]
- (2024): Cousin F+, Rev Med Liege (French) 79(5-6), 418-423
- (2024): Ganguli A+, J Assoc Physicians India 72(1), 74-80 [REVIEW]
- (2024): Joung JY+, Pharmaceuticals (Basel) 17(5), 544 [REVIEW]
- (2024): Lyrio RMDC+, Front Nephrol Aug, Online ahead of print [REVIEW]
- (2024): Yu CH+, Medicina (Kaunas) 60(8), 1302 [REVIEW]
Drug-induced disease (Skin)
- (2024): Brameli A+, J Allergy Clin Immunol Pract Jun, Online ahead of print [REVIEW]
- (2024): Bray ER+, Arch Dermatol Res 316(6), 233 (ICI-associated epidermal necrosis should be considered a distinct clinical entity from drug-induced SJS/TEN.)
- (2024): Chow TG+, Curr Opin Pediatr Aug, Online ahead of print [REVIEW]
- (2024): Fan M+, Front Pharmacol Jul (e-Collection) (pharmacovigilance / pharmacoepidemiology)
- (2024): Hung SI+, Nat Rev Dis Primers 10(1), 30 [REVIEW]
- (2024): Jiménez-Andrade Y+, Hematol Oncol Clin North Am Jun, Online ahead of print [REVIEW]
- (2024): Kemanetzi C+, Dermatol Pract Concept Jul (e-Collection)
- (2024): Lu Y+, Front Immunol Jul (e-Collection) (63 cases)
- (2024): Samarakoon U+, J Am Acad Dermatol Apr, Online ahead of print
- (2024): Temido MJ+, Am J Gastroenterol Oct, Online ahead of print [REVIEW]
- (2024): Tetart F+, J Eur Acad Dermatol Venereol Jul [REVIEW]
- (2024): Ubukata N+, J Am Acad Dermatol May, Online ahead of print [REVIEW]
- (2023): Etesami I+, Australas J Dermatol 64(1), 41-49 [REVIEW]
- (2023): Parisi R+, Am J Clin Dermatol 24(4), 557-575 [REVIEW]
- (2022): Del Pozzo-Magaña BR+, Br J Clin Pharmacol Aug, Online ahead of print [REVIEW]
- (2021): Schuler AM+, J Cutan Pathol 48(12), 1471-1479 [REVIEW]